Posted on June 7, 2021 by Stylianos Hatzakis FDA approves Biogen’s Alzheimer’s drug, the first new therapy for the disease in nearly two decades Home » News, Insights & Trends » Business » FDA approves Biogen’s Alzheimer’s drug, the first new therapy for the disease in nearly two decadesShareThe drug, which is marketed under the name Aduhelm, is expected to generate billions of dollars in revenue for the company. Read More Related posts:"The Power of AI in Business and Entrepreneurship: Unlocking Opportunities and Driving Success""The Power of AI: Revolutionizing Business and Empowering Entrepreneurs"Margaritaville Aims to Hang On After Jimmy Buffett’s DeathPork Industry Grapples With Whiplash of Shifting Regulations Post navigationPrevious post: Facebook won’t take a cut from creators until 2023, Zuckerberg says in shot at AppleNext post: The Fed is in early stages of a campaign to prepare markets for tapering its asset purchases